EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus

Nikica Sabljic, Jecko Thachil, Nikola Pantic, Mirjana Mitrovic

Research and Practice in Thrombosis and Haemostasis · 2024-07 · 8 (5) · 102499

DOI: 10.1016/j.rpth.2024.102499 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2024-07. Verfasst von Nikica Sabljic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coagulopathy continues to be a major challenge in the management of patients with acute promyelocytic leukemia (APL). Novel differentiating agents have led to improved survival in these patients, but perturbations in coagulation continue to have an impact on their prognosis. The most worrisome of coagulation disturbances is bleeding, which is not an uncommon cause of early death in APL. Despite this, there are no consistent predictors of this high risk of fatal hemorrhage in APL. In this context, the fibrinolytic system has been identified as a crucial role player in APL coagulopathy. However, the current guidelines for the management of APL give little regard to tests that measure the fibrinolytic system while giving more importance to close monitoring of conventional coagulation tests and platelet counts to identify the coagulopathy. More recently, viscoelastic tests have come to usefulness in determining global hemostasis and have been widely used for "diagnosing" hyperfibrinolysis in selected clinical settings. In this review, we attempt to describe risk assessment models for diagnosing APL coagulopathy, describe the possible application of viscoelastic tests in this setting, and persuade clinicians to reconsider the use of antifibrinolytics to improve survival of APL patients.

Schlagwörter

Stichwörter der Autor:innen

acute promyelocytic leukemiableedingfibrinolysis

Autor:innen und Institutionen

  • Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia.
  • Department of Hematology, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Zitieren

APA

Sabljic, N., Thachil, J., Pantic, N., & Mitrovic, M. (2024). Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus. Research and Practice in Thrombosis and Haemostasis, 8(5), 102499. https://doi.org/10.1016/j.rpth.2024.102499

Vancouver

Sabljic N, Thachil J, Pantic N, Mitrovic M. Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus. Research and Practice in Thrombosis and Haemostasis. 2024;8(5):102499. doi:10.1016/j.rpth.2024.102499

BibTeX
@article{Sabljic2024,
  author = {Sabljic, Nikica and Thachil, Jecko and Pantic, Nikola and Mitrovic, Mirjana},
  title = {Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  year = {2024},
  volume = {8},
  number = {5},
  pages = {102499},
  doi = {10.1016/j.rpth.2024.102499}
}
Kostenlos starten →